Does folate deficiency impair remethylation of homocysteine to methionine and raise homocysteine levels?

Folate is a critical regulator of one-carbon metabolism, and its deficiency is a primary cause of hyperhomocysteinemia, especially in older adults. For a 73-year-old female, maintaining adequate folate status is essential to prevent the accumulation of homocysteine, which is linked to cardiovascular and neurodegenerative risks.

Mechanistic explanations

Folate deficiency disrupts the remethylation cycle by depleting the supply of 5-methyltetrahydrofolate (5-MTHF), the specific methyl donor required for the enzyme methionine synthase (MTR).

• The Reaction: MTR facilitates the transfer of a methyl group from 5-MTHF to homocysteine, converting it into methionine. This reaction requires Vitamin B12 (cobalamin) as an essential cofactor.
• The Bottleneck: When folate levels are low, the lack of 5-MTHF creates a metabolic bottleneck. Homocysteine cannot be efficiently recycled, leading to its accumulation in the blood.
• The Methyl-Folate Trap: In states of impaired remethylation (often caused by B12 deficiency), folates can become "trapped" as 5-MTHF. Because the MTR reaction is the only way to regenerate tetrahydrofolate (THF) from 5-MTHF, the entire folate cycle stalls, further aggravating the deficiency and impairing DNA synthesis and methylation.
• S-adenosylmethionine (SAM): The methionine produced via remethylation is the precursor to SAM, the body's universal methyl donor. Impaired remethylation reduces SAM availability, which can compromise the methylation of DNA, proteins, and neurotransmitters.

Clinical evidence

Clinical data consistently show a strong inverse relationship between folate levels and homocysteine concentrations.

• Intervention Studies: Randomized trials in elderly populations (ages 60–90) demonstrate that folic acid supplementation reduces homocysteine levels in a dose-dependent manner. For example, daily folic acid can lower homocysteine levels by 20–30% in individuals with low baseline folate.
• B12 Co-dependence: In older adults, Vitamin B12 deficiency often co-occurs with or mimics folate deficiency in its effect on homocysteine. In countries with mandatory folic acid fortification, B12 status is frequently the primary nutritional determinant of elevated homocysteine.
• Age-Related Factors: Research indicates that the elderly are at higher risk for hyperhomocysteinemia due to decreased dietary intake, malabsorption issues, or age-related changes in enzyme efficiency.

Bottom line

The claim is strongly supported: folate deficiency impairs the remethylation of homocysteine by depleting the 5-MTHF substrate. This directly causes elevated serum homocysteine levels and reduces the production of the vital methyl donor SAM. In older populations, monitoring both folate and B12 is essential for maintaining this metabolic pathway.